Brinker Capital’s Incyte INCY Stock Holding History

Brinker Capital’s Portfolio INCY Stock Details INCY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q4	–	Sell	-1,792	Closed	-$209K	–	992
2017 Q3	$209K	Buy	+1,792	New	+$227K	0.01%	906

Other funds holding INCY

BBA

Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Sands Capital Management Arlington, Virginia $26.9B AUM 34.44% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

BB Biotech Schaffhausen, Switzerland $3.98B AUM 15.47% 1-Year Est. Return

Brinker Capital's INCY Position: Q4 2017 in Review

Brinker Capital sold out of Incyte (INCY) in Q4 2017, closing a stake of 1,792 shares — an estimated $209K sold.

Brinker Capital first reported a position in INCY in Q3 2017 and held it in 1 quarter. The position peaked at $209K in Q3 2017. 503 funds tracked by Wall St. Rank hold INCY as of Q4 2017.

Brinker Capital reported no remaining Incyte position as of Q4 2017 after selling out during the quarter.
Brinker Capital sold 1,792 Incyte shares in Q4 2017, an estimated $209K.
Brinker Capital first reported a position in Incyte in Q3 2017 and held it in 1 quarter.
Brinker Capital's Incyte position peaked at $209K in Q3 2017.
503 funds tracked by Wall St. Rank held Incyte as of Q4 2017.

Based on Brinker Capital's 13F filing for Q4 2017, filed 14 Feb 2018.